Calculating Pre-test Probability of Coronary Artery Disease
Use the Risk Factor-weighted Clinical Likelihood (RF-CL) model to calculate pre-test probability, which incorporates age, sex, symptom characteristics (0-3 points), dyspnea characteristics (0-2 points), and number of cardiovascular risk factors (0-5 points) to generate a percentage likelihood of obstructive CAD. 1
The RF-CL Model Components
Symptom Score (0-3 points)
- Substernal chest discomfort (1 point) 1
- Provoked by physical exertion or emotional stress (1 point) 1
- Relieved by rest and/or nitroglycerin (1 point) 1
Dyspnea Score (0-2 points)
- Shortness of breath and/or trouble catching breath aggravated by physical exertion (2 points) 1
Risk Factors (0-5 points total)
Count one point for each present:
- Family history of CAD (first-degree relative with CAD: men <55 years, women <65 years) 1
- Current or past smoking 1
- Dyslipidemia 1
- Hypertension 1
- Diabetes mellitus 1
Interpreting the Pre-test Probability
The 2024 ESC guidelines classify likelihood as follows:
- Very low: ≤5% - Defer further diagnostic testing 1
- Low: >5%-15% - Consider coronary artery calcium scoring (CACS) to reclassify patients 1
- Moderate: >15%-50% - Proceed with CCTA or functional imaging 1
- High: >50%-85% - Proceed with non-invasive testing 1
- Very high: >85% - Assume obstructive CAD is present; focus on risk stratification rather than diagnosis 1
Adjusting the Initial Estimate
After calculating the RF-CL score, adjust the pre-test probability using additional clinical data: 1
- Peripheral artery disease on examination - increases likelihood 1
- Resting ECG abnormalities (Q waves, ST-T wave changes) - increases likelihood 1
- Regional wall motion abnormalities on resting echocardiography - increases likelihood 1
- Vascular calcifications on prior imaging - increases likelihood 1
- CACS = 0 in low probability patients - reclassifies to very low probability 1
Selecting the Appropriate Diagnostic Test
Very Low Probability (≤5%)
No further testing is recommended - the risk of false positives exceeds the benefit of testing 1, 2
Low Probability (>5%-15%)
CACS is the preferred initial test to reclassify patients and identify those with very low CACS-weighted clinical likelihood 1
Alternatively, consider:
Moderate Probability (>15%-50%)
CCTA is recommended as the preferred diagnostic modality to rule out obstructive CAD 1
- CCTA has 95-99% sensitivity for detecting obstructive CAD 2
- If CCTA shows CAD of uncertain functional significance, proceed to functional imaging 1
- Sequential testing (functional test after CCTA or vice versa) is often needed to establish accurate diagnosis 1
High to Very High Probability (>50%)
Functional imaging for myocardial ischemia is recommended 1
Options include:
- Exercise stress imaging (echo or SPECT/PET) if patient can exercise with normal baseline ECG 1
- Vasodilator stress perfusion imaging (sensitivity 90-91% for SPECT, 81-97% for PET) if patient cannot exercise or has LBBB/paced rhythm 2
- Dobutamine stress echocardiography (sensitivity 79-83%) if vasodilator stress is contraindicated 2
Critical Pitfalls to Avoid
The older Diamond-Forrester and 2013 ESC models vastly overestimate CAD prevalence in contemporary populations - they classify 97% of patients as intermediate probability when actual prevalence is only 13.9% 3, 4. The 2024 RF-CL model corrects this overestimation and has been validated in large contemporary cohorts 4.
Do not perform exercise ECG as the sole test in moderate-to-high probability patients - its sensitivity is only 45-50%, leading to excessive false negatives 2. Imaging-based tests are superior in this population 1.
Avoid testing when pre-test probability is <5% or >85% - in these ranges, the number of false test results exceeds correct results, making testing harmful rather than helpful 2.
Always adjust the RF-CL estimate with additional clinical data before finalizing the diagnostic strategy - resting ECG, echocardiography, and peripheral artery examination significantly improve accuracy 1.